Shanghai Medicilon Inc (688202) - Total Liabilities

Latest as of June 2025: CN¥749.64 Million CNY ≈ $109.70 Million USD

Based on the latest financial reports, Shanghai Medicilon Inc (688202) has total liabilities worth CN¥749.64 Million CNY (≈ $109.70 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shanghai Medicilon Inc cash flow conversion to assess how effectively this company generates cash.

Shanghai Medicilon Inc - Total Liabilities Trend (2016–2024)

This chart illustrates how Shanghai Medicilon Inc's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Shanghai Medicilon Inc's assets to evaluate the company's liquid asset resilience ratio.

Shanghai Medicilon Inc Competitors by Total Liabilities

The table below lists competitors of Shanghai Medicilon Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Pan Jit International Inc TW:2481	Taiwan	NT$13.84 Billion
VIX Securities JSC VN:VIX	Vietnam	₫12.71 Trillion
Gempharmatech Co. Ltd. A SHG:688046	China	CN¥630.58 Million
SINOPEC Engineering (Group) Co. Ltd F:1NS	Germany	€56.36 Billion
Genusplus Group Ltd AU:GNP	Australia	AU$311.19 Million
LianChuang Electronic Technology Co Ltd SHE:002036	China	CN¥14.30 Billion
Foschini Group Ltd JSE:TFG	South Africa	ZAC36.01 Billion
Beijing VRV Software Corp Ltd SHE:300352	China	CN¥781.19 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Shanghai Medicilon Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688202 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.70	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Medicilon Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Medicilon Inc (2016–2024)

The table below shows the annual total liabilities of Shanghai Medicilon Inc from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥683.10 Million ≈ $99.96 Million	-9.53%
2023-12-31	CN¥755.07 Million ≈ $110.49 Million	+3.89%
2022-12-31	CN¥726.80 Million ≈ $106.35 Million	+55.94%
2021-12-31	CN¥466.06 Million ≈ $68.20 Million	+103.81%
2020-12-31	CN¥228.67 Million ≈ $33.46 Million	+79.02%
2019-12-31	CN¥127.73 Million ≈ $18.69 Million	+2.13%
2018-12-31	CN¥125.06 Million ≈ $18.30 Million	+22.27%
2017-12-31	CN¥102.29 Million ≈ $14.97 Million	+3.52%
2016-12-31	CN¥98.81 Million ≈ $14.46 Million	--

About Shanghai Medicilon Inc

SHG:688202 China Biotechnology

Market Cap

$1.22 Billion

CN¥8.34 Billion CNY

Market Cap Rank

#8312 Global

#2138 in China

Share Price

CN¥62.10

Change (1 day)

-1.83%

52-Week Range

CN¥30.19 - CN¥81.10

All Time High

CN¥394.88